NCT06348446View on ClinicalTrials.gov

Tacrolimus Exposure in Kidney Transplantation

RecruitingOBSERVATIONAL

Enrollment

12,000

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

July 30, 2024

Study Completion Date

August 30, 2024

Conditions

Kidney Transplant Rejection

Trial Locations (4)

Unknown

RECRUITING

Asan medical center, Seoul, Korea, Seoul

RECRUITING

Samsung medical center, Seoul, Korea, Seoul

RECRUITING

Seoul St. Mary's hospital, Seoul, Korea, Seoul

RECRUITING

Severance hospital, Seoul, Korea, Seoul

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT06348446 - Tacrolimus Exposure in Kidney Transplantation | Biotech Hunter | Biotech Hunter